New York, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Research Nester has published a detailed market report on ‘Global Female Stress Urinary Incontinence Treatment Devices Market’ for the forecast period, i.e. 2023 – 2033 which includes the following factors:
- Market growth over the forecast period
- Detailed regional synopsis
- Market segmentation
- Growth drivers
- Challenges
- Key market players and their detailed profiling
Global Female Stress Urinary Incontinence Treatment Devices Market Size:
By the end of 2033, the global market for female stress urinary incontinence treatment devices is anticipated to generate revenues of USD 1200.3 million, expanding at a CAGR of 6% over the forecast period. Additionally, the market garnered USD 667.1 million in revenue in 2022. The growth of the market can be attributed to the increasing number of treatments for female stress urinary incontinence across the world. In 2019, it has been noted that more than 280,000 procedures are carried out annually.
Get a Sample PDF Brochure: https://www.researchnester.com/sample-request-4376
In addition to this, the increasing government initiatives to promote awareness regarding female stress urinary incontinence is predicted to boost market growth during the forecast period. It was found that in order to deliver evidence-based community health information and boost community health resiliency, the United States established a "Women's Health Awareness (WHA)" inside the National Institute of Environmental Health Sciences. Further, the rising investment by key market players and the healthcare sector in the field of research and development is anticipated to drive market growth.
Global Female Stress Urinary Incontinence Treatment Devices Market: Key Takeaways
- North America region gains the largest portion of the revenue
- Electrical stimulation segment to dominate the revenue graph
- Hospitals sub-segment remains prominent in the end-user segment
Increase in Instances of Urinary Incontinence and Rising Prevalence of Medical Disorders to Boost Market Growth
The rising cases of urinary incontinence across the world is estimated to propel market growth. It was observed that the incidence of urinary incontinence in women ranged between 10%-65%. Further, stress incontinence is becoming more common in the geriatric population as old age females are more prone to acquire chronic illnesses which can lead to urine incontinence. Therefore, the growing geriatric population across the globe is anticipated to drive market growth over the forecast period.
For more information in the analysis of this report, visit: https://www.researchnester.com/reports/female-stress-urinary-incontinence-treatment-devices-market/4376
Moreover, female stress urinary incontinence treatment devices are expected to sell better as a result of medical disorders including Parkinson's disease, multiple sclerosis, muscular damage, loss of rectum storage capacity, and many others. Additionally, the rising prevalence of these medical disorders across the world is estimated to boost market growth during the forecast period. As the global estimates in 2019, over 8.5 million people have Parkinson’s disease doubled in 25 years.
Global Female Stress Urinary Incontinence Treatment Devices Market: Regional Overview
The global female stress urinary incontinence treatment devices market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa region.
Increasing Healthcare Expenditure to Drive Growth in the North America Region
As of 2022, the market in the North American area has the largest market share of 41%. Further, the market is estimated to gain noteworthy market share over the forecast period owing to the availability of well-established healthcare infrastructure, and increasing spending on healthcare in the region. It was noticed that in 2020, American healthcare expenditures were USD 4000 billion. Additionally, the strong presence of key market players and rising female population to drive market growth in the region.
Get a Sample PDF of Female Stress Urinary Incontinence Treatment Devices Market Report@ https://www.researchnester.com/sample-request-4376
Increasing Neurological Diseases to Drive Growth in the Asia Pacific Region
On the other hand, the market in Asia Pacific region is estimated to witness significant market growth over the forecast period owing to the increasing burden of neurological diseases which in turn predicted to raise the cases of urinary incontinence. For instance, in 2019, 64.4 million people in southeast Asia and 85 million people in western pacific regions were diagnosed with neurological disorders. In addition to this, the increasing awareness among the people regarding urinary incontinence and improving healthcare facilities in the region are predicted to drive market growth over the estimated time period.
The study further incorporates Y-O-Y growth, demand & supply and forecast future opportunity in:
- North America (U.S., Canada)
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe)
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
- Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific)
- Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).
Global Female Stress Urinary Incontinence Treatment Devices Market, Segmentation by End-User
-
- Hospitals
- Gynecological Clinics
- Home Care Settings
Out of these, the hospitals segment is anticipated to hold the largest market size by the end of 2033 and to grow further over the forecast period owing to the rising healthcare infrastructure across the globe. It was found that the total number of all U.S hospitals was 6,093 in 2022. In addition to this, the increasing patient pool in the hospital and rising awareness among the people regarding the importance of proper diagnosis and treatment of the disorder is anticipated to boost the segment’s growth.
For more insights on the market share of various regions: https://www.researchnester.com/sample-request-4376
Global Female Stress Urinary Incontinence Treatment Devices Market, Segmentation by Type
- Urethral Sling
- Artificial Urinary Sphincters
- Electrical Stimulation Devices
- Catheters
Among these, the electrical stimulation devices segment holds the largest market share of 54.42% as of 2022 and is predicted to gain significant market share over the forecast period owing to their ease of operation, and cost-effectiveness with the great convenience of being self- administered at home. Further, the segment growth is projected based on the increasing prevalence of musculoskeletal and central nervous system illnesses, which are the leading causes of urinary incontinence. According to World Health Organization, every year around 1.71 billion people suffer from musculoskeletal issues, with 568 million of those suffering from lower back pain, and up to 1 billion people get affected by neurological disorders.
Global Female Stress Urinary Incontinence Treatment Devices Market, Segmentation by Product Type
- Sling Systems
- Pessaries
- Injectable Urethral Bulking Agents
Few of the well-known market leaders in the global female stress urinary incontinence treatment devices market that are profiled by Research Nester are Boston Scientific Corporation, Johnson & Johnson Services, Inc., Becton, Dickinson and Company, Coloplast Corp., CooperSurgical Inc., MedGyn Products, Inc., Cousin Biotech, Caldera Medical, Inc, Betatech Medical, FEG Textiltechnik MbH, and others.
Do You Have Any Query Or Specific Requirement?
Recent Developments in the Global Female Stress Urinary Incontinence Treatment Devices Market
- In June 2022, Leva, a pelvic health system to treat women with urinary incontinence, has been accepted by researchers, according to Renovia Inc.
- In October 2018, Solyx, a one-incision incision sling device, was successful in treating women with stress urinary incontinence, according to Boston Scientific Corporation.
Explore Our Recent Related Reports:
Sexually Transmitted Disease Testing Market Analysis by Disease (Human Immunodeficiency Virus, Herpes Simplex Virus, Human Papillomavirus, Chlamydia, Syphilis, Gonorrhea, Cancroid and Others); by Location (Laboratory, and Point of Care); and by Device (Laboratory Devices, and Point of Care Devices) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
Breast Implants Market Analysis by Product (Saline, Silicon, Smooth, Implant, and Tissues Expanders); by Shape (Anatomical and Round); by Procedure (Breast Augmentation and Breast Reconstruction); and by End-User (Specialty Clinics and Hospitals) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
Antibiotics Market Analysis by Drug Class (Beta Lactam & Beta Lactamase Inhibitors, Macrolide, and Others); by Drug Origin (Natural, Semisynthetic, and Synthetic); by Spectrum of Activity (Broad-Spectrum, and Narrow-Spectrum Antibiotics); by Indication (Skin Infections, Respiratory, Gastrointestinal, UTIs, Blood Stream, Clostridium Difficile, Ear Infections, and Others); and by End-User (Hospitals, Specialty Clinics, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
Fibrin Sealants Market Analysis by Type (Liquid, Patch, and Powder); by Application (General Surgery, Cardiovascular Surgery, Thoracic Surgery, Orthopedic Surgery, Transplant Surgery, Neurosurgery, Dental Surgery, Wound Management, and Others); by Technology (Autologous Donation, Viral Inactivation, Recombinant Production, and Others); and by End-User (Hospitals, Ambulatory Surgical Centers, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
Fibromyalgia Treatment Market Analysis by Drug Class (Antidepressants, Antiepileptic, Muscle Relaxants, and Others); by Type (Symptomatic Treatment, and Targeted Treatment); and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
About Research Nester
Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.
Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
For More Update Follow: - LinkedIn | Twitter | Facebook | Xing
